What does Apollo Hospitals do?

Apollo Hospitals Enterprise Ltd. is a leading private healthcare provider in Asia, with a market cap of Rs 99,858 Cr and reported net sales of 5,592 Cr and net profit of 390 Cr for March 2025. The company has a P/E ratio of 68.00 and a return on equity of 17.61%.

Overview: <BR>Apollo Hospitals Enterprise Ltd. is a leading private sector healthcare provider in Asia, operating within the hospital industry and categorized as a large-cap company.<BR><BR>History: <BR>Apollo Hospitals Enterprise Ltd. was incorporated in an unspecified year and has maintained its status as a prominent player in the healthcare sector. The latest quarterly results reported are for March 2025, showing significant sales and profit figures.<BR><BR>Financial Snapshot: <BR>- Net Sales: 5,592 Cr (Quarterly Results - Mar 2025) <BR>- Net Profit: 390 Cr (Quarterly Results - Mar 2025) <BR>- Market Cap: Rs 99,858 Cr (Large Cap) <BR><BR>Key Metrics: <BR>- P/E: 68.00 <BR>- Industry P/E: 54 <BR>- Dividend Yield: 0.28% <BR>- Debt-Equity: 0.62 <BR>- Return on Equity: 17.61% <BR>- Price to Book: 12.04 <BR><BR>Contact Details: <BR>Address: No 19 Bishop Garden, Raja Annamalaipuram Chennai Tamil Nadu : 600028 <BR>Tel: 91-44-28290956/28293896 <BR>Email: apolloshares@vsnl.net <BR>Website: http://www.apollohospitals.com

When is the next results date for Apollo Hospitals?

No Upcoming Board Meetings

Who are in the management team of Apollo Hospitals?

As of March 2023, the management team of Apollo Hospitals includes Prathap C Reddy (Executive Chairman), Preetha Reddy (Executive Vice Chairperson), Suneeta Reddy (Managing Director), and several independent directors, playing a key role in the company's strategic direction and governance.

As of March 2023, the management team of Apollo Hospitals includes:<BR><BR>1. Prathap C Reddy - Executive Chairman<BR>2. Preetha Reddy - Executive Vice Chairperson<BR>3. Suneeta Reddy - Managing Director<BR>4. Sangita Reddy - Joint Managing Director<BR>5. Shobana Kamineni - Executive Vice Chairperson<BR>6. S M Krishnan - Senior Vice President & Company Secretary<BR>7. Vinayak Chatterjee - Independent Director<BR>8. Murali Doraiswamy - Independent Director<BR>9. V Kavitha Dutt - Independent Director<BR>10. M B N Rao - Lead Independent Director<BR>11. Som Mittal - Independent Director<BR>12. Rama Bijapurkar - Independent Director<BR><BR>This diverse team plays a crucial role in the strategic direction and governance of the company.

Has Apollo Hospitals declared dividend?

Yes, Apollo Hospitals has declared a dividend of 180%, amounting to ₹9 per share, with an ex-date of February 14, 2025. The company has shown strong total returns over various periods, particularly a 413.31% total return over the last 5 years.

Apollo Hospitals Enterprise Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 180%<BR>- Amount per share: 9<BR>- Ex-date: 14 Feb 25<BR><BR>Dividend Yield: 0.28%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -4.24%, the dividend return was 0.12%, resulting in a total return of -4.12%.<BR><BR>Over the past year, the price return was 16.16%, the dividend return was 0.31%, leading to a total return of 16.47%.<BR><BR>In the 2-year period, the price return was 39.97%, the dividend return was 0.66%, culminating in a total return of 40.63%.<BR><BR>For the 3-year period, the price return was 90.39%, the dividend return was 1.37%, resulting in a total return of 91.76%.<BR><BR>In the 4-year period, the price return was 104.65%, the dividend return was 1.58%, leading to a total return of 106.23%.<BR><BR>Finally, over the last 5 years, the price return was 409.09%, the dividend return was 4.22%, resulting in a total return of 413.31%.<BR><BR>Overall, Apollo Hospitals has declared a substantial dividend, and the total returns over various periods indicate strong performance, particularly over the longer term, showcasing significant growth in both price and dividends.

Who are the peers of the Apollo Hospitals?

Apollo Hospitals' peers include Max Healthcare, Fortis Health, Narayana Hrudaya, and others. Key metrics show excellent management risk and capital structure at several peers, with Krishna Institu. leading in 1-year returns at 85.23%, while Apollo Hospitals has a 1-year return of 16.20%.

Peers: The peers of Apollo Hospitals are Max Healthcare, Fortis Health., Narayana Hrudaya, Global Health, Aster DM Health., Krishna Institu., Rainbow Child., Dr Agarwal's Hea, Jupiter Life Lin, and Health.Global.<BR><BR>Quality Snapshot: Excellent management risk is observed at Max Healthcare, Narayana Hrudaya, Global Health, Krishna Institu., Rainbow Child., Dr Agarwal's Hea, Jupiter Life Lin, and the rest. Good growth is noted at Max Healthcare, Apollo Hospitals, Narayana Hrudaya, Dr Agarwal's Hea, and the rest, while Average growth is found at Fortis Health., Global Health, and the rest. Average capital structure is seen at Apollo Hospitals, while Excellent capital structure is noted at Max Healthcare, Global Health, Krishna Institu., Jupiter Life Lin, and the rest, and Below Average capital structure is observed at Aster DM Health.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Krishna Institu. at 85.23%, while the lowest is Dr Agarwal's Hea with N/A, and Apollo Hospitals has a 1-year return of 16.20%. Additionally, Aster DM Health. and Dr Agarwal's Hea have negative six-month returns.

Who are the top shareholders of the Apollo Hospitals?

The top shareholders of Apollo Hospitals include M/s. Pcr Investments Ltd with 18.93%, Foreign Institutional Investors holding 43.49%, and mutual funds with 15.94%. The highest public shareholder is Mirae Asset Midcap Fund at 2.21%, while individual investors own 3.98%.

The top shareholders of Apollo Hospitals include a mix of institutional and individual investors. The largest shareholder is M/s. Pcr Investments Ltd, which holds 18.93% of the company. Foreign Institutional Investors (FIIs) are significant stakeholders, collectively holding 43.49%. Additionally, mutual funds are represented by 324 schemes, accounting for 15.94% of the shares. The highest public shareholder is Mirae Asset Midcap Fund, with a holding of 2.21%. Individual investors collectively own 3.98% of the company.

How big is Apollo Hospitals?

As of 24th July, Apollo Hospitals Enterprise Ltd. has a market capitalization of 106,791.00 Cr, with recent net sales of 21,794.00 Cr and a net profit of 1,445.90 Cr. The company reported shareholder's funds of 6,935.40 Cr and total assets of 16,742.20 Cr for the annual period ending in March 2024.

As of 24th July, Apollo Hospitals Enterprise Ltd. has a market capitalization of 106,791.00 Cr, categorizing it as a Large Cap company.<BR><BR>In the latest four quarters, Apollo Hospitals reported Net Sales of 21,794.00 Cr and a Net Profit of 1,445.90 Cr.<BR><BR>For the latest annual period ending in March 2024, the company had Shareholder's Funds amounting to 6,935.40 Cr and Total Assets of 16,742.20 Cr.

Is Apollo Hospitals overvalued or undervalued?

As of October 30, 2025, Apollo Hospitals is considered undervalued with an attractive valuation grade, featuring a PE ratio of 71.16, a lower PEG ratio of 1.37 compared to peers, and an 11.30% return over the past year, outperforming the Sensex's 5.58%.

As of 30 October 2025, Apollo Hospitals has moved from a fair to an attractive valuation grade, indicating a shift in its perceived value. The company is currently considered undervalued, particularly when compared to its peers. Key ratios include a PE ratio of 71.16, an EV to EBITDA of 36.59, and a ROE of 17.61%. <BR><BR>In comparison to its peers, Apollo Hospitals stands out with a lower PEG ratio of 1.37, while competitors such as Max Healthcare and Fortis Health are deemed very expensive with PE ratios of 94.85 and 85.21, respectively. Additionally, despite a slight decline in the past week, Apollo Hospitals has outperformed the Sensex over the past year with a return of 11.30% compared to the Sensex's 5.58%, reinforcing its attractive valuation in the current market.

Are Apollo Hospitals latest results good or bad?

Apollo Hospitals' latest Q2 FY26 results are positive, with a 12.78% year-on-year revenue growth to ₹6,303.50 crores and a net profit increase of 25.98% to ₹477.20 crores, indicating strong operational efficiency and demand in the healthcare sector.

Apollo Hospitals' latest results for Q2 FY26 can be considered quite positive. The company reported robust revenue growth of 12.78% year-on-year, reaching ₹6,303.50 crores, which is the highest quarterly revenue in its history. Additionally, operating profit margins improved significantly to 14.93%, marking the highest level in at least eight quarters. <BR><BR>Net profit also showed strong performance, growing 25.98% year-on-year to ₹477.20 crores, with a net profit margin of 7.84%, up from 7.08% in the same quarter last year. This indicates not only a solid top-line growth but also effective cost management and operational efficiency.<BR><BR>The sequential growth was also notable, with net profit increasing by 10.26% quarter-on-quarter, reflecting sustained demand across its hospital network and diversified healthcare services. Furthermore, the company achieved a return on equity of 17.61%, showcasing strong capital efficiency.<BR><BR>Overall, the results reflect Apollo Hospitals' ability to capitalize on the growing healthcare demand in India while maintaining disciplined cost management, positioning the company favorably for continued growth in the future.

How has been the historical performance of Apollo Hospitals?

Apollo Hospitals has shown consistent growth in net sales and profitability, with net sales increasing from 9,617.44 Cr in Mar'19 to 21,794.00 Cr in Mar'25, and profit after tax rising from 199.18 Cr to 1,472.10 Cr in the same period. The company has also improved its earnings per share from 16.97 to 100.55 and demonstrated strong asset growth.

Answer:<BR>The historical performance of Apollo Hospitals shows a consistent growth trajectory in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Apollo Hospitals has demonstrated significant growth in net sales, increasing from 9,617.44 Cr in Mar'19 to 21,794.00 Cr in Mar'25. The total operating income followed a similar trend, reaching 21,794.00 Cr in Mar'25, up from 16,612.50 Cr in Mar'23. The operating profit (PBDIT) also rose notably, from 1,095.10 Cr in Mar'19 to 3,222.10 Cr in Mar'25, reflecting an operating profit margin of 13.87% in the latest year. Profit before tax surged to 2,006.10 Cr in Mar'25, with profit after tax reaching 1,472.10 Cr, marking a significant increase from 199.18 Cr in Mar'19. The earnings per share (EPS) improved dramatically from 16.97 in Mar'19 to 100.55 in Mar'25. On the balance sheet, total assets grew from 11,288.80 Cr in Mar'20 to 20,644.30 Cr in Mar'25, while total liabilities increased from 11,288.80 Cr to 20,644.30 Cr in the same period. Cash flow from operating activities has also shown positive growth, reaching 2,136.00 Cr in Mar'25, contributing to a closing cash balance of 578.00 Cr. Overall, Apollo Hospitals has exhibited robust financial performance with increasing revenues, profits, and asset growth over the years.

Should I buy, sell or hold Apollo Hospitals?

Is Apollo Hospitals technically bullish or bearish?

As of December 3, 2025, Apollo Hospitals shows a mildly bearish trend, driven by bearish signals from the MACD, KST, and OBV on weekly and monthly charts, despite some mixed indicators from Bollinger Bands and daily moving averages.

As of 3 December 2025, the technical trend for Apollo Hospitals has changed from sideways to mildly bearish. The current technical stance is mildly bearish. Key indicators driving this stance include the MACD on both weekly and monthly time frames showing mildly bearish signals, along with the KST and OBV also indicating mild bearishness on the weekly and monthly charts. The Bollinger Bands present a mixed view, being bearish on the weekly but mildly bullish on the monthly. The daily moving averages suggest a mildly bullish position, but this is overshadowed by the overall bearish indicators in the longer time frames.

Which are the latest news on Apollo Hospitals?

Why is Apollo Hospitals falling/rising?

As of 14-Dec, Apollo Hospitals Enterprise Ltd. is seeing a stock price increase to 7,102.65 after a trend reversal from five days of decline, although it remains below key moving averages. Despite a recent rise, investor participation has decreased, and the stock has a -1.84% return over the past year, but strong financial fundamentals indicate healthy growth.

As of 14-Dec, Apollo Hospitals Enterprise Ltd. is experiencing a rise in its stock price, currently at 7,102.65, with a change of 92.85 (1.32%) upwards. This upward movement follows a trend reversal, as the stock has gained after five consecutive days of decline. Despite this recent rise, the stock is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating that it has not yet regained its previous momentum.<BR><BR>The stock's performance today has outperformed its sector by 0.39%, suggesting a positive shift in investor sentiment. However, it is important to note that there has been a decline in investor participation, with delivery volume falling by 5.85% compared to the 5-day average. This could indicate a cautious approach from investors despite the recent price increase.<BR><BR>On a broader scale, while the stock has generated a return of -1.84% over the past year, its profits have risen by 41.3%, reflecting strong underlying financial health. The company boasts a high return on capital employed (ROCE) of 16.84% and a low debt to EBITDA ratio of 1.48 times, which supports its ability to service debt effectively. Furthermore, Apollo Hospitals has shown healthy long-term growth, with net sales increasing at an annual rate of 16.66% and operating profit at 37.14%.<BR><BR>In summary, the recent rise in Apollo Hospitals' stock price can be attributed to a trend reversal after a period of decline, positive sector performance, and strong financial fundamentals, despite some concerns regarding declining investor participation.